Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that cutaneous manifestations in children with systemic lupus erythematosus differ from adults, with no female preponderance and less frequent photosensitivity and vascular lesions.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

This article reviews challenges in diagnosing new-onset SLE during pregnancy, emphasizing the complexity of distinguishing it from normal pregnancy changes and preeclampsia, and reports no new results.

This study observed that certain skin symptoms in SLE, such as malar rash and photosensitivity, are linked to systemic involvement, indicating their potential role as markers for disease activity.

The combination of minoxidil and cyclosporine improved hair growth in short anagen syndrome.

This case report describes a female patient with systemic lupus erythematosus who developed generalized hair-follicle hamartoma, marking the fourth documented association between the two conditions.

This study found that low-dose intermittent corticosteroid therapy may be a successful and well-tolerated treatment option for patients with alopecia areata, including those with alopecia totalis and universalis.

This review identifies sebaceous gland disorders as key indicators of hormonal imbalances, detailing how various hormones affect sebaceous function, and emphasizes a multidisciplinary approach to improve diagnosis and management by integrating endocrine, metabolic, and dermatologic insights.

This study found that women with central centrifugal cicatricial alopecia had a substantial prevalence of systemic comorbidities, including strong associations with dyslipidemia, uterine leiomyomas, and anxiety disorders.

D-chiral biomaterial scaffolds enhance tissue and hair regeneration by activating the body's immune system.

In this case report, a 48-year-old woman with kerion celsi showed improvement with a regimen including antifungal, bacterial, and adjunctive treatments, though the specific role of mesenchymal stromal cell secretome could not be isolated from the other therapies.

This study conducted in Peshawar, Pakistan, observed that individuals with Long COVID frequently reported systemic symptoms such as hair loss, headache, and fatigue, along with oral issues like loss of taste and dry mouth, highlighting the importance of incorporating oral symptom assessments in post-COVID care.

This retrospective cohort study found that individuals with alopecia totalis or universalis have a higher prevalence of systemic autoimmune diseases, particularly endocrine diseases and inflammatory bowel disease, compared to those with patchy alopecia areata.

This study found that arthritis and mucocutaneous features are common at early stages of SLE, while sicca, vasculitis, and hematologic manifestations tend to increase as the disease progresses.

This study analyzed systemic treatment patterns in 262 French children with severe alopecia areata, finding that while intravenous corticosteroids were most commonly used initially, treatment effectiveness appeared limited with frequent relapses and a need for prolonged therapy, but without serious adverse events.

This study found that systemic testosterone exposure in transgender individuals with XX genotype alters skin biology, increasing androgen and estrogen receptor-positive cells, collagen density, and fibronectin expression while reducing immune cells, which could affect surgical outcomes by promoting a male skin phenotype.

In this study, patient-reported flare symptoms after COVID-19 vaccination in individuals with systemic lupus erythematosus were generally mild, with 17% experiencing flares mostly characterized by joint pain and fatigue; vaccine type did not affect flare incidence.

In this study, PRP combined with systemic therapy for androgenetic alopecia showed higher, but not statistically significant, improvements in hair density and width compared to PRP alone, with no increase in side effects; further prospective studies are recommended.

This study found that androgenetic alopecia patients treated with a combination of PRP and systemic therapy experienced greater but non-significant improvements in hair density and width compared to PRP monotherapy, without additional adverse effects, suggesting potential benefits for further exploration of combination regimens.

This study found that combining platelet-rich plasma with systemic therapies for androgenetic alopecia may result in greater improvements in hair density and width than using PRP alone, though the differences were not statistically significant.

This review article connects key systemic lupus erythematosus pathobiology with current therapies, emphasizes clinical strategies for managing comorbidities, and stresses multidisciplinary care, but it reports no new clinical findings.

The authors concluded that for alopecia areata, addressing psychosocial well-being and social functioning is crucial, as the burden of the condition extends beyond visible hair loss and includes substantial inequities in treatment access.

Topical hair loss treatments have a stronger placebo effect than systemic ones.

Topical treatments for hair loss have a stronger placebo effect than systemic ones.

This case report highlights a 42-year-old woman with systemic lupus erythematosus who exhibited fundus changes indicating retinal vasculitis, underlining the importance of regular ocular fundus examinations for early detection of severe disease complications.

This case report illustrates that prompt diagnosis and treatment of myositis in an SLE patient can lead to symptom resolution and highlights this condition as a rare SLE complication.

In this study, a systematic review found that for androgenetic alopecia, systemic treatments like finasteride, dutasteride, and oral minoxidil are effective at slowing progression and promoting hair regrowth, with additional antiandrogen therapy options for women.

This review highlights that iron deficiency is a significant yet often overlooked contributor to the development of immune-mediated inflammatory skin diseases, suggesting that iron dysregulation may drive inflammation and metabolic imbalances in conditions like psoriasis and atopic dermatitis.

This study found that patients with chronic, persistent alopecia areata experience significant psychosocial impairments unrelated to scalp hair loss, which influence their decision to start systemic therapy.

In this case study, a 12-year-old boy with alopecia totalis experienced hair regrowth on the side of his scalp treated with a combination of systemic steroids and dithranol, suggesting a potential synergistic effect that may help manage severe alopecia areata with minimal side effects.